"Radical" abdominal cancer surgery: current state and future course

Area of Science:

• Surgical Oncology
• Gastrointestinal Oncology
• Cancer Biology

Background:

• Biologically driven cancer surgery is crucial for optimal patient care.
• Advancements in technology and understanding of tumor biology enhance radical surgical safety and efficacy.
• Early-stage abdominal cancers are localized and amenable to surgical intervention.

Purpose of the Study:

• To evaluate the effectiveness of biologically driven, radical cancer surgery.
• To present long-term outcomes for liver, pancreatic, and biliary tract cancers treated with advanced surgical techniques.

Main Methods:

• Review of surgical cases including 1103 liver tumor operations (415 resections) and 62 regional pancreatectomies since 1970 and 1979, respectively.
• Focus on en bloc resection of primary tumors and regional lymphatic drainage.
• Analysis of survival data for various abdominal malignancies.

Main Results:

• Major hepatic resections were performed in 359 patients with liver tumors.
• For 33 patients with stage 1 or 2 pancreatic head adenocarcinoma, 5-year survival was 31%.
• Significant improvements observed in treating ampullary, periampullary, gallbladder, and extrahepatic bile duct cancers.

Conclusions:

• Radical, biologically driven surgery demonstrates substantial improvements in treating abdominal cancers.
• Effective surgical management can lead to better cure rates, particularly when cancer is not yet widespread.
• Continued advancements in surgical oncology offer improved prognoses for patients with gastrointestinal malignancies.